Edition:
United States

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

577.60INR
20 Jan 2017
Change (% chg)

Rs-2.75 (-0.47%)
Prev Close
Rs580.35
Open
Rs583.80
Day's High
Rs592.50
Day's Low
Rs574.40
Volume
1,100,568
Avg. Vol
1,261,668
52-wk High
Rs617.80
52-wk Low
Rs457.45

Select another date:

Wed, Nov 9 2016

UPDATE 1-India's Cipla Q2 profit falls as Europe, emerging markets suffer

MUMBAI, Nov 9 Cipla Ltd, India's fifth-largest drugmaker by sales, on Wednesday reported a 35 percent fall in quarterly profit, missing analysts' estimates, mainly due to lower sales in the emerging markets and Europe.

India's Cipla Q2 profit falls 35 pct

MUMBAI, Nov 9 Cipla Ltd, India's fifth-largest drugmaker by sales, on Wednesday reported a 35 percent fall in quarterly profit, missing analysts' estimates.

BRIEF-Cipla Sept qtr consol profit falls

* Consensus forecast for Sept quarter consol net profit was 3.92 billion rupees

BRIEF-Cipla gets EIR from USFDA for its Indore facility

* Cipla receives EIR from the US FDA for its Indore facility Source text: http://bit.ly/2e8Sy2g Further company coverage: (Bengaluru newsroom)

India's Cipla Q1 profit lags estimates; names new CEO

MUMBAI, Aug 12 Cipla Ltd, India's fifth-largest drugmaker by sales, reported a lower-than-expected quarterly profit as revenues in its home market were hit by government measures to cut drug prices.

Select another date: